Home Our expertise Commercial Portfolio, Licensing & Development

Portfolio, Licensing & Development.

Build and optimize your product and portfolio value.

What we do.

Prepare for lasting clinical and commercial success when you build and optimize your product and portfolio value with us. Science-based, future-focused, and comprehensive, our strategies provide sound guidance for your most critical clinical development, opportunity prioritization, and go/no-go decisions.

How we help.

With a unique blend of clinical and scientific expertise, innovative business strategy, and more than three decades of strategic experience, we advise on optimal and sustainable pharmaceutical portfolio analysis and diligence and early pipeline strategies.

Rooted in a strong understanding of the science and evolving market, we can help your crossfunctional teams understand where to position their earlystage assets and platforms in the future landscape, and how to optimize their clinical development path and maximize the asset value.

We can help you with:

  • Target screening and prioritization
  • Current and emerging disease landscape
  • Opportunity prioritization
  • Clinical development and regulatory strategy
  • Technology and asset scans to support BD&L
  • Due diligence and inlicensing/outlicensing structuring
  • Longterm portfolio strategy, planning, and optimization

Get to know some of our experts.

John L’Ecuyer

Executive Director, Business Development

Joseph Feingold

Partner, Portfolio, Licensing & Development Practice Lead & Head of Advanced Technologies Center of Excellence

Vikram Gosain


Get in touch.

Looking to get in touch with an expert or team member?

Tell us how we can help.